Citations

Showing 10 of 108162 citations.

The turbinates in nasal and sinus surgery: A consensus statement
Rice, Dale H., Kern, Eugene B. , Marple, Bradley F., Mabry, Richard L., Friedman, William H.

Mayo Clinic

Ear, Nose & Throat Journal | November 4, 2019 | Volume: 82 | Issue: 2 | Pages: 82-84

10.1177/014556130308200202 Get It

A panel to discuss various issues concerning surgery of the middle and inferior turbinates in patients with nasal and sinus disease was convened by the American Rhino-logical Society during the Combined Otolaryngological Spring Meetings in May 2001. The panel was chaired by the lead author (D.H.R.) and made up of the other authors listed above. What follows are some of the highlights of the presentations and the panelists’ conclusions and consensus recommendations.
The long‐term impact of providing nursing education in a low‐income country
Holm, Michelle R., Burkhartzmeyer, Holly L. , Fort, Rachel, Rinville, Raymonde, Sannon, Herriot

Mayo Clinic

Public Health Nursing | November 4, 2019 | Volume: 37 | Issue: 1 | Pages: 65-72

10.1111/phn.12681 | PMID 31682021 Get It

AbstractObjectiveTo measure long‐term knowledge gain after provision of nursing education in a low‐income country.Design and SampleGlobal health education research has often focused on the short‐ term effects of providing education and direct patient care. Assessment of long‐term knowledge gain is key for determining whether education knowledge transfer is sustainable.MeasurementsThis prospective cohort study of educational training for nurses in Haiti tested knowledge gain before, immediately after, and 6 months after education.InterventionQuantitative assessments were obtained through multiple choice tests at 3 time points. Qualitative data were obtained through focus groups and self‐assessments.ResultsKnowledge gain was significant from pretest to immediate posttest, and knowledge retention was assessed at 6 months after the education. Qualitative data showed improvement in reported confidence levels and patient care activities. Short‐term knowledge gain was statistically significant for improvement; however, long‐term knowledge gain was statistically significant in only 4 of 19 lectures.ConclusionsReported qualitative improvements in patient care indicated added value of providing education to the nursing staff. Hands‐on learning techniques were important to long‐term retention, and building trust was vital to the completion of our study.
Histological stroke clot analysis after thrombectomy: Technical aspects and recommendations
Staessens, Senna , Andersson, Tommy , Clarençon, Frédéric , Denorme, Frederik , Gounis, MJ, Hacke, Werner , Liebeskind, DS, Szikora, István , Es, ACGM van, Brinjikji, Waleed , Doyle, KM, Meyer, SF De, Liebeskind, David S. , Staessens, S , Liebeskind, David S. , Szikora, Istvan , Andersson, Tommy , Fitzgerald, Seán , De Meyer, Simon F

Mayo Clinic

International Journal of Stroke | November 4, 2019 | Volume: 15 | Issue: 5 | Pages: 467-476

10.1177/1747493019884527 | PMID 31679478 Get It

The recent advent of endovascular procedures has created the unique opportunity to collect and analyze thrombi removed from cerebral arteries, instigating a novel subfield in stroke research. Insights into thrombus characteristics and composition could play an important role in ongoing efforts to improve acute ischemic stroke therapy. An increasing number of centers are collecting stroke thrombi. This paper aims at providing guiding information on thrombus handling, procedures, and analysis in order to facilitate and standardize this emerging research field.
Identification of several plasma proteins whose levels in colorectal cancer patients differ depending on outcome
Holm, Matilda , Joenväärä, Sakari , Saraswat, Mayank , Mustonen, Harri , Tohmola, Tiialotta , Renkonen, Risto, Haglund, Caj , Ristimäki, Ari

Mayo Clinic

FASEB BioAdvances | November 2, 2019 | Volume: 1 | Issue: 12 | Pages: 723-730

10.1096/fba.2019-00062 | PMID 32123817 Get It

Abstract Colorectal cancer (CRC) stands for 10% of the worldwide cancer burden and has recently become the second most common cause of cancer death. The 5‐year survival rate depends mainly on stage at diagnosis. Mass spectrometric proteomic analysis is widely used to study the plasma proteome, which is complex and contains multitudes of proteins. In this study, we have used Ultra Performance Liquid Chromatography‐Ultra Definition Mass Spectrometry (UPLC‐UDMS E )‐based proteomics to analyze plasma samples from 76 CRC patients. We identified several plasma proteins, such as CP, TVP23C, FETUB, and IGFBP3, of which altered levels led to significant differences in survival, as seen by Cox regression and Kaplan‐Meier analysis. Additionally, during Cox regression analysis, samples were adjusted for age and/or tumor stage, enabling stringent analysis. These proteins, although in need of further validation, could be of use during patient follow‐up, as their levels can non‐invasively be measured from blood samples, and could be of use in predicting patient outcome. Several of these proteins additionally have roles in metabolism and inflammation, two processes central to the development and progression of cancer, further indicating their importance in cancer.
The Levothyroxine Absorption Test: A Four-Year Experience (2015–2018) at The Mayo Clinic
Gonzales, Kristen , Stan, Marius N. , Bernet, Victor , Castro, M. Regina , Gonzales, Kristen M, Stan, Marius N , Morris, John C.

Mayo Clinic

Thyroid® | November 2, 2019 | Volume: 29 | Issue: 12 | Pages: 1734-1742

10.1089/thy.2019.0256 | PMID 31680654 Get It

Background: Levothyroxine (LT4) is the mainstay of therapy for hypothyroidism. Yet, despite physician efforts at dose titration, some patients remain hypothyroid on LT4 doses in excess of weight-based calculations, a condition known as refractory hypothyroidism. The LT4 absorption test (LT4AT) has been proposed to have utility in these patients by enabling distinction of LT4 malabsorption from pseudomalabsorption, a condition of intentional nonadherence. Given its rare use in clinical practice, we reviewed our institution's experience with the LT4AT to assess its impact on management of refractory hypothyroidism. Methods: We reviewed the charts of 16 patients diagnosed with refractory hypothyroidism and who had completed the LT4AT between January 2015 to January 2019. The primary aim was to determine the utility of this test in distinguishing LT4 malabsorption from pseudomalabsorption. Secondary aims were to determine whether the results of this test impacted physicians' management decisions, as well as to report on clinical outcomes at follow-up. Our LT4AT is a six-hour test wherein patients receive a weight-based dose of LT4 followed by serial measurements of total thyroxine (TT4) and thyrotropin (TSH). Percentage absorption is calculated using the following formula, with normal absorption being ≥60%: Results: Percentage absorption was calculated in 13 of 16 patients due to lack of TT4 data for 3 patients. Absorption was impaired in one patient (% absorbed = 0), who had known causes of malabsorption. The remaining 12 patients had normal absorption by hour 4 of the test (% absorption 60–158) in conjunction with upward TT4 trends. Clinical follow-up ranged from 1 to 32 months (median 6.5 months), with 11 patients having follow-up data. Six of these had normal or suppressed TSH values at most recent follow-up, and four had improved but persistent TSH elevations. The one said patient with malabsorption improved with intravenous LT4. Conclusions: The LT4AT can provide valuable information for distinguishing malabsorption from pseudomalabsorption. Our findings support the combined use of calculated percentage absorptions with TT4 trends for at least a four-hour time frame when making determinations regarding absorption.
Risk of internal carotid artery stenosis or occlusion after single-fraction radiosurgery for benign parasellar tumors
Graffeo, Christopher S. , Link, Michael J. , Stafford, Scott L., Foote, Robert L. , Pollock, Bruce E. , Parney, Ian F.

Mayo Clinic

Journal of Neurosurgery | November 2, 2019 | Volume: 133 | Issue: 5 | Pages: 1388-1395

10.3171/2019.8.jns191285 | PMID 31653808 Get It

OBJECTIVEStereotactic radiosurgery (SRS) is an accepted treatment option for patients with benign parasellar tumors. Here, the authors’ objective was to determine the risk of developing new or progressive internal carotid artery (ICA) stenosis or occlusion after single-fraction SRS for cavernous sinus meningioma (CSM) or growth hormone–secreting pituitary adenoma (GHPA).METHODSThe authors queried their prospectively maintained registry for patients treated with single-fraction SRS for CSM or GHPA in the period from 1990 to 2015. Study criteria included no prior irradiation and ≥ 12 months of post-SRS radiological follow-up. Pre-SRS grading of ICA involvement was applied according to the 1993 classification schemes of Hirsch for CSM or Knosp for GHPA.RESULTSThe authors conducted a retrospective review of 283 patients, 155 with CSMs and 128 with GHPAs. Ninety-three (60%) CSMs were Hirsch category 2 and 3 tumors; 97 (76%) GHPAs were Knosp grade 2–4 tumors. Median follow-up after SRS was 6.6 years (IQR 1–24.9 years). No GHPA or category 1 CSM developed ICA stenosis or occlusion. Three (5.2%) patients with category 2 CSMs had asymptomatic ICA stenosis (n = 2) or occlusion (n = 1); 1 (1.1%) category 2 CSM patient had transient ischemic symptoms. Five (14.3%) category 3 CSMs progressed to ICA occlusion (4 asymptomatic, 1 symptomatic). The median time to stenosis/occlusion was 4.8 years (IQR 1.8–7.6). Five- and 10-year risks of ICA stenosis/occlusion in category 2 and 3 CSM patients were 7.5% and 12.4%, respectively. Five- and 10-year risks of ischemic stroke from ICA stenosis/occlusion in category 2 and 3 CSM patients were both 1.2%. Multivariate analysis showed patient age (HR 0.92, 95% CI 0.86–0.98, p = 0.01), meningioma pathology (HR and 95% CI not defined, p = 0.03), and pre-SRS carotid category (HR 4.51, 95% CI 1.77–14.61, p = 0.004) to be associated with ICA stenosis/occlusion. Internal carotid artery stenosis/occlusion was not related to post-SRS tumor growth (HR and 95% CI not defined, p = 0.41).CONCLUSIONSNew or progressive ICA stenosis/occlusion was common after SRS for CSM but was not observed after SRS for GHPA, suggesting a tumor-specific mechanism unrelated to radiation dose. Pre-SRS ICA encasement or constriction increases the risk of ICA stenosis/occlusion; however, the risk of ischemic complications is very low.
Prostate Cancer Outcomes Following Solid-Organ Transplantation: A SEER-Medicare Analysis
Liauw, Stanley L. , Das, Lauren C., Rudra, Sonali, Packiam, Vignesh T. , Becker, Yolanda T. , Bodzin, Adam S. , Eggener, Scott E. , Liauw, Stanley L , Ham, Sandra A. , Koshy, Matthew , Weichselbaum, Ralph R.

Mayo Clinic

JNCI: Journal of the National Cancer Institute | November 1, 2019 | Volume: 112 | Issue: 8 | Pages: 847-854

10.1093/jnci/djz221 | PMID 31728517 Get It

Abstract Background Immunosuppressive regimens associated with organ transplantation increase the risk of developing cancer. Transplant candidates and recipients with prostate cancer are often treated, even if low-risk features would ordinarily justify active surveillance. Methods Using SEER-Medicare, we identified 163 676 men aged 66 years and older diagnosed with nonmetastatic prostate cancer. History of solid organ transplant was identified using diagnosis or procedure codes. A propensity score-matched cohort was identified by matching transplanted men to nontransplanted controls by age, race, region, year, T-stage, grade, comorbidity, and cancer therapy. Fine-Gray competing risk models assessed associations between transplant status and prostate cancer-specific mortality (PCSM) and overall mortality (OM). Results We identified 620 men (0.4%) with transplant up to 10 years before (n = 320) or 5 years after (n = 300) prostate cancer diagnosis and matched them to 3100 men. At 10 years, OM was 55.7% and PCSM was 6.0% in the transplant cohort compared with 42.4% (P < .001) and 7.6% (P = .70) in the nontransplant cohort, respectively. Adjusted models showed no difference in PCSM for transplanted men (hazard ratio = 0.88, 95% confidence interval = 0.61 to 1.27, P = .70) or differences by prostate cancer therapy. Among 334 transplanted men with T1-2N0, well or moderately differentiated “low-risk” prostate cancer, PCSM was similar for treated and untreated men (hazard ratio = 0.92, 95% confidence interval = 0.47 to 1.81). Conclusions Among men aged 66 years and older with prostate cancer, an organ transplant is associated with higher OM but no observable difference in PCSM. These findings suggest men with prostate cancer and previous or future organ transplantation should be managed per usual standards of care, including consideration of active surveillance for low-risk cancer characteristics.
Incidental diagnosis and surgery outcomes of thyroid cancer in Ecuador
Salazar-Vega, Jorge , García, Cristhian, Ortiz‐Prado, Esteban , Ledesma, Tannya, Rojas, Tatiana, Alvarado-Mafla, Benjamin , Cárcamo, César , Solís-Pazmiño, Paola , Lincango-Naranjo, Eddy , Jaramillo-Koupermann, Gabriela , Rojas, Tatiana, Carcamo, Cesar, Ponce, Oscar J. , Brito, Juan P.

Mayo Clinic

No container title available | November 1, 2019 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.2.16716/v1 Get It

Abstract Background: In contrast to the rapid increase in thyroid cancer (TC) incidence, thyroid cancer mortality rates have remained low and stable over the last decades. In Ecuador, however, TC mortality has increased and to determine possible drivers, a retrospective analysis of all patients attending a thyroid cancer referral center in Ecuador was conducted. Methods: From June 2014 to December 2017, a cross-sectional study was conducted at the Hospital de Especialidades Eugenio Espejo (HEEE), a regional reference public hospital for endocrine neoplasia in adults in Quito, Ecuador. We identified the mechanism of detection, histopathology and treatment modalities from a patient interview and review of clinical records. Results: Among 452 patients, 74.8% were young adults and 94.2% (426) of patients were female. 13.7% had a family history of thyroid cancer, and median of tumor size was 2 cm. The incidental finding was 54.2% whereas 45.8% was non-incidental. Thyroid cancer histology reported that 93.3% had papillary thyroid cancer (PTC), 2.7% follicular, 1.5% Hurtle cells, 1.6% medullary, 0.7% poor differentiated, and 0.2% anaplastic carcinoma. The mean MACIS (metastasis, age, completeness, invasion, and size) score was 4.95 (CI 4.15-5.95) with 76.2% of the thyroid cancer patients having MACIS score equal or less than 6. The very low and low risk of recurrence was 18.1% (79) and 62% (271) respectively. An analysis of 319 patients with non-metastatic thyroid cancer showed that 10.7% (34) of patients had surgical complications. Moreover, around 62.5% (80 from 128 patients with thyroglobulin laboratory results) of TC patients had a stimulated-thyroglobulin (sTg) value equal or higher than 2 ng/ml. Overall, a poor surgical outcome was present in 35.1% (112) patients. Out of 436 patients with differentiated thyroid carcinoma (DTC), 86% (n=375) received radioactive iodine (RAI). Conclusion: Thyroid cancer histological characteristics and method of diagnosis are like the ones described in other reports without any evidence of the high frequency of aggressive thyroid cancer histology. However, we observed evidence of overtreatment and poor surgical outcomes that demand additional studies to understand their association with thyroid cancer mortality in Ecuador.
A primary care modification of family-based treatment for adolescent restrictive eating disorders
Lebow, Jocelyn , O’Brien, Janna R. Gewirtz , Mattke, Angela, Narr, Cassandra, Geske, Jennifer R. , Billings, Marcie, Clark, Matthew M. , Grange, Daniel Le , Sim, Leslie , Geske, Jennifer, Jacobson, Robert M. , Phelan, Sean, Le Grange, Daniel , Sim, Leslie A , Lebow, Jocelyn , Geske, Jennifer , Phelan, Sean M.

Mayo Clinic

Eating Disorders | November 1, 2019 | Volume: 29 | Issue: 4 | Pages: 376-389

10.1080/10640266.2019.1656468 | PMID 31675286 Get It

Stigma and Disclosure in Patients With Inflammatory Bowel Disease
Guo, Ling , Rohde, Jacob A. , Farraye, Francis A.

Mayo Clinic

Inflammatory Bowel Diseases | November 1, 2019 | Volume: 26 | Issue: 7 | Pages: 1010-1016

10.1093/ibd/izz260 | PMID 32556190 Get It

Abstract Stigma in patients suffering from chronic disease is associated with worse clinical outcomes and secondary medical issues such as depression, anxiety, and decreased quality of life. We believe various forms of stigma can have different clinical significance in patients with inflammatory bowel disease (IBD). With further insight and research, we suggest that these forms of stigma could be identified and targeted by researchers or clinicians to lessen the psychological disease burden in patients and to potentially improve their physical well-being. In the current review, we discuss public perceptions, knowledge, and stigmatization of IBD, the prevalence of various forms of IBD stigma, and the impact of such stigma on patient outcomes. We also discuss IBD disclosure, its association with stigma, and the tendencies and effects of such disclosures among youth and adult patient populations. We finish the review by highlighting possible modalities and research areas for future IBD interventions.